Practical daily management of extrarenal continuous removal;Gestion pratique de l'épuration extrarénale continue au quotidien

Reanimation

Volumn 17, Issue 5, 2008, Pages 472-477

  Honore, P M ^a   Joannes Boyau, O ^b   Collin, V ^c   Boer, W ^d   Gressens, B ^a   Janvier, G ^b  

^a Service des soins intensifs   (Belgium)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Cliniques de l'Europe   (Belgium)

^d Atrium Medical Parkstad Centre   (Netherlands)

Author keywords

Blood flow; CVVH; Dose; Hemofiltration; Membranes; Pre and postdilution

Indexed keywords

CLINICAL PRACTICE; CONTINUOUS HEMOFILTRATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; MEDICAL STAFF; NURSING STAFF; SHORT SURVEY; SURVIVAL; VASCULAR ACCESS;

EID: 45949091674     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2008.04.008     Document Type: Short Survey

References (39)

1. Honore P.M., Joannes-Boyau O., Merson L., Boer W., Piette V., and Galloy A.C. The big bang of haemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification. Inter J Artif Organs 29 (2006) 649-659
2. Ronco C., Homel P., Bellomo R., Dan M., Piccinni P., and La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 (2000) 26-30
3. Saudan P., Niederberger M., De Seigneux S., Romand J., Pugin J., Pemeger T., et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70 (2006) 1312-1317
4. ANZICS clinical trials group. Augmented vs. normal renal replacement therapy in severe acute renal failure (ARF) (renal study) Clinicaltrials.gov/ct2/show/NCT00221013.
5. Palevsky P.M., O'Connor T., Zhang J.H., Star R.A., and Smith M.V. Design of the VA/NIH Acute Renal Failure Trial Network (ATN) study: intensive versus conventional renal support in acute renal failure. Clin Trials 2 (2005) 423-435
6. Fishel R.S., Are C., and Barbul A. Vessel injury and capillary leak. Crit Care Med 31 (2003) 502-511
7. Honore P.M., Piette V., Galloy A.C., Almpanis C., Pelgrim J.P., and Dugernier T. Hémofiltration a haut volume : revue générale. In: Robert R., Honoré P.M., and Bastien O. (Eds). Circulations extracoporelles en réanimation. SRLF Collection Europe (2006), Elsevier, Paris 195-221
8. Mandolfo S., Galli F., Costa S., Ravani P., Gaggia P., and Imbasciati E. Factors influencing permanent catheter performance. J Vasc Access 2 (2001) 106-109
9. Joannidis M., and Oudemans-van Straaten H.M. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 11 (2007) 218-222
10. Uchino S., Cole L., Morimatsu H., Goldsmith D., Ronco C., and Bellomo R. Solute mass balance during isovolaemic high volume haemofiltration. Intensive Care Med 29 (2003) 1541-1546
11. Aucella F., Di Paolo S., and Gesualdo L. Dialysate and replacement fluid composition for CRRT. Contrib Nephrol 156 (2007) 287-296
12. Renard D., Douny N., Verly Ch, Lourtie A.M., and Honore P.M. Surveillance infirmière de l'hémofiltration continue. In: Robert R., Honoré P.M., and Bastien O. (Eds). Circulations extracoporelles en réanimation. SRLF Collection Europe (2006), Elsevier, Paris 179-194
13. Honore P.M., and Joannes-Boyau O. High volume hemofiltration in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Inter J Artif Organs 27 (2004) 1077-1082
14. Lafargue M., Joannes-Boyau O., Honore P.M., Gauche B., Grand H., Fleureau C., et al. Acquired deficit of antithrombin and role of supplementation in septic patients during continuous veno-venous hemofiltration. Asaio J 54 (2008) 124-128
15. du Cheyron D., Bouchet B., Bruel C., Daubin C., Ramakers M., and Charbonneau P. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study. Crit Care 10 (2006) R45
16. Jean G., Chazot C., Vanel T., Charra B., Terrat J.C., Calemard E., et al. Central venous catheters for haemodialysis: looking for optimal blood flow. Nephrol Dial Transplant 12 (1997) 1689-1691
17. Meeus G., Kuypers D.R., Claes K., Evenepoel P., Maes B., and Vanrenterghem Y. A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters. Blood Purif 23 (2005) 101-105
18. Bouman C.S., Van Olden R.W., and Stoutenbeek C.P. Cytokine filtration and adsorption during pre and post-dilution haemofiltration in four differents membranes. Blood Purif 16 (1998) 261-268
19. Leypold J.K., Jarsted S., and Frigon R.P. Temperature dependance of macromacular sieving across plasma fractionating membranes. ASAIO Trans 34 (1988) 420-424
20. Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Predilution vs post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 94 (2003) 94-98
21. Langsdorf L.J., and Zidney A.L. Effect of blood contact on transport properties of haemodialysis membrane: a two layer membrane model. Blood Purif 12 (1994) 292-307
22. Monti G., Herrera M., Kindgen-Milles D., Marinho A., Cruz D., Mariano F., et al. The dose response multicentre international collaborative initiative (DO-RE-MI). Contrib Nephrol 156 (2007) 434-443
23. Unger J.K., Lemke A.J., and Grosse-Siestrup C. Thermography as potential real-time technique to assess changes in flow distribution in hemofiltration. Kidney Int 69 (2006) 520-525
24. Boyd R.F., and Zydney A.L. Analysis of protein fouling during hemofiltration using a two layer membrane model. Biotechnol Bioeng 59 (1998) 451-460
25. Mehta A., and Zydney A.L. Effect of membrane charge on flow and protein transport during ultrafiltration. Biotechnol Prog 22 (2006) 484-492
26. Honoré P.M., Zydney L.A., and Matson J.R. High volume and high permeability haemofiltration for sepsis: the evidence and the key issues. Care Crit ill 19 (2003) 69-76
27. Matson J.R., Zydney A.R., and Honore P.M. Blood filtration: new opportunities and the implications on system biology. Crit Care Resusc 6 (2004) 209-218
28. Blatt W.F., Michaels D.A.S., and Nelson L. Solute polarisation and cake formation in membrane ultrafiltrate: causes, consequences and control techniques. In: Flinn J.E. (Ed). Membrane science and technology (1970), Plenium press 47-97
29. Dungen H.G., Von heymann C., Ronco C., Kox W.J., and Spies C.D. Renal replacement therapy: physical properties of hollow fiber influence efficiency. Int J Artif Organs 24 (2001) 357-366
30. Ronco C., Brendolan A., Capelli G., Balestri N., Inguaggiato P., Fortunato L., et al. In vitro and in vivo evaluation of a new polysulfone membrane for hemodialysis. Reference methodology and clinical results (Part I: in vitro study). Int J Artif Organs 22 (1999) 604-615
31. Wolff S.H., and Zydney A.L. Effects of peracetic acid reprocessing on the transport characteristics of polysulfone hemodialyzes. Artif Organs 29 (2005) 166-173
32. Tan H.K., Uchino S., and Bellomo R. Electrolyte mass balance during CVVH: lactate vs. bicarbonate-buffered replacement fluids. Ren Fail 26 (2004) 149-153
33. Honore PM, Joannes-Boyau O, Boer W, Janvier G. CRRT induced alkalosis in ICU patients: the questions start here. Crit Care Med: In press.
34. Journois D. Quelle est la place de l'hémodiafiltration ? Mapar 2007, www.hemofiltration.org (consulté le 10 février 2008).
35. Joannes-Boyau O., Honore PM. Haemofiltration Study: IVOIRE (hIgh VOlume in Intensive Care). Clinicaltrials.gov/ct2/show/NCT00241228 (consulté le 6 janvier 2008).
36. Bell M., Swin G., Granath F., Schon S., Ekbom A., and Martling C.R. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 33 (2007) 773-780
37. Jacka M.J., Ivancinova X., and Gibney R.T. Continuous renal replacement therapy improves renal recovery from acute renal failure. Can J Anaesth 52 (2005) 327-332
38. Honore P.M., Joannes-Boyau O., and Boer W. The early biomarker of acute kidney injury ki: in search of the holy grail. Intensive Care Med 33 (2007) 1866-1868
39. Honore P.M., Joannes-Boyau O., Boer W., Janvier G., and Gressens B. Acute Kidney Injury in the ICU: time has come for an early biomarker kit. Acta Clinica Belgica 62 (2007) 318-322